Product logins

Find logins to all Clarivate products below.


Biosurgical Agents | Market Insights | Europe (Supplemental) | 2022

Procedure deferrals due to the COVID-19 pandemic severely impacted the European biosurgical agent market in 2020, and the elective nature of many postponed procedures will hinder the pace of recovery to some extent. However, as the situation improves, the European biosurgical agent market will grow modestly through the forecast period, driven by continuing growth in biosurgical procedures, rising awareness of the clinical benefits of these products on surgical outcomes, and the introduction of new products with enhanced features and expanded indications.

This Medtech 360 Report provides high-level market metrics for laparoscopic devices in Europe, including country-level data for major countries and aggregate data for the rest of Europe, across an 11-year period.

Related Medtech Insights Reports

Report
Interventional Oncology Devices – Market Insights – Europe
The European interventional oncology device market is projected to see modest growth through 2034, driven by rising cancer incidence and prevalence rates, updated clinical guidelines, and emerging…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Europe
The European GI endoscopy device market will be primarily driven by the high incidence of gastric cancer and CRC cases in the region. Growth will be supported by nationwide CRC and GI cancer…
Report
Urological Devices – Market Insights – Europe
The European urological device market is set to grow through 2034, driven by product innovation, rising awareness, increasing kidney stone cases, and an aging population. Growth will be led by BPH…
Report
Gynecological Devices – Market Insights – Europe
The European gynecological device market will see marginal growth over the forecast period, fueled by the ongoing adoption of office-based treatments, the increasing preference for minimally…
Report
Heart Valve Devices – Market Insights – Europe
The European heart valve device market will continue to observe moderate growth, particularly due to growing demand for minimally invasive cardiac interventions boosting the adoption of THV devices…